This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.

Rosa Tye

Principal

Rosa Tye is a principal in CRA’s Life Sciences Practice. She is a life sciences and healthcare strategy consultant with more than eight years of experience advising pharmaceutical and biotech clients across a range of functions, including commercial, market access, medical affairs, and public affairs.

Rosa consults on a mix of global commercial strategy and market access issues across a broad range of therapeutic areas, with a focus in oncology, rare disease, and endocrinology.

Related capabilities
Related capabilities

Selected engagements

  • 01
    Payer reactions to 2024 IRA MFP negotiations and implications for access strategy
    A leading pharmaceutical company sought support in understanding payer reactions to the 2024 IRA MFP negotiations and implications for Commercial plan
    View engagement
  • 02
    US go-to-market business strategy and market mapping for cell therapies in oncology
    A team of CRA Life Sciences consultants successfully assisted the client, an academic medical center (AMC), by using market research to identify key factors...
    View engagement

Recent events

Credentials

Get In Touch
Rosa Tye
Oakland +1-617-425-6461 rtye@crai.com